Skip to content
Medical Health Aged Care

Monash expert: Moderate to severe MS and pregnancy

Monash University < 1 min read

A Monash University-led study published in JAMA Network Open was the first to examine the impact of pregnancy on multiple sclerosis (MS) relapse activity and long-term disability progression in women with moderate to severe disability. Most previous research has focused on women with mild MS-related disability.

Similar to findings in women with minimal disability, MS relapse rates decrease during pregnancy and increase in the first three months postpartum in women with more significant MS disability. Pregnancy does not worsen long-term disability outcomes in this population.

Available to comment:

Dr Jessica Shipley, Monash Department of Neuroscience, School of Translational Medicine
Contact: +61 3 9903 4840 or [email protected] 

  • Neurology

  • Multiple sclerosis

  • Pregnancy

Comments attributable to Dr Shipley:

“Until now, we have not had an evidence base that we could use to advise women with moderate to severe MS-related disability about the likely impact of pregnancy on their long-term MS outcomes.

“Our findings provide reassurance that pregnancy does not accelerate long-term disability in women living with more significant MS-related impairment.

“This research helps inform pregnancy counselling for women with moderate to severe MS-related disability, giving them clearer information to support family planning decisions.

“By focusing on a group that has been largely understudied, we’re building a more complete understanding of how pregnancy affects MS across the full spectrum of disability.”

For more experts, news, opinion and analysis, visit Monash News.

For any other topics on which you may be seeking expert comment, contact the Monash University Media Unit on +61 3 9903 4840 or [email protected] 

More from this category

  • Indigenous, Medical Health Aged Care
  • 26/03/2026
  • 10:00
Charles Darwin University

CDU EXPERT: Fuel crisis causing inequitable access to health care and food security

26MARCH,2026 Who:ProfessorofIndigenous HealthYvette Roe,Directorof theMollyWardagugaInstitute for First Nations Birth RightsatCharles DarwinUniversity. Topics: Rising fuel prices and the impact this will have on food security and the health and well-being of mums and bubs Food security Contact details:Call +61 8 8946 6721 or email [email protected] to arrange an interview. Quotes attributable toProfessorYvette Roe: “Aboriginal women and girls in this in our remote Territory communities experience some of the poorest sexual, reproductive, maternal, infant, and child health outcomes in Australia (e.g. preterm birth rates are regularly the highest in the country at 18-22%). Acute poverty, overcrowding, limited employment opportunity and food security are keysocio-economic determinants for a thriving mother and babyduringacross the lifecourse. “Mums andbabies whorequireregular check-ups, antenatal care, and access to nutritious food and prenatal vitamins are most at risk…

  • Government Federal, Medical Health Aged Care
  • 26/03/2026
  • 06:10
Australian College of Nursing

Let nurse practitioners lead Urgent Care Clinics to address staffing issues

The Australian College of Nursing is calling on the Federal Government to revise guidelines to allow nurse practitioners to lead care independently in Medicare Urgent Care Clinics (UCCs), with GP recruitment an ongoing challenge for the program. Nurse practitioners are among the most highly qualified clinicians in our health system, capable of leading UCCs, but the current Medicare Urgent Care Clinic Program Operational Guidance mandates that clinics will be GP-led, with a vocationally registered general practitioner required at a minimum. The latest evaluation of the program noted recruitment of appropriately qualified doctors remains an issue, and that Medicare Benefits Schedule…

  • Contains:
  • Medical Health Aged Care
  • 26/03/2026
  • 06:00
Monash University

New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder

Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto natural fat absorption pathways to allow oral delivery of some drugs previously requiring injection. The research, published today inScience Translational Medicine, describes the first clinical evidence that a fat, or lipid, modified version of the naturally occurring neurosteroid allopregnanolone (GlyphAllo™) can result in high enough levels of the substance in the human bloodstream to be potentially effective. The endogenous neurosteroid allopregnanolone is a well-established molecule known for its clinically validated antidepressant, anti-anxiety and sleep-promoting effects – but to this point had to be…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.